Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2025)

Precision Biosciences (DTIL) has disclosed Other Operating Expenses for 4 consecutive years, with $3000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $3000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$213000.0, a 72.62% increase, with the full-year FY2024 number at -$436000.0, up 5.42% from a year prior.
  • Other Operating Expenses was $3000.0 for Q3 2025 at Precision Biosciences, up from -$25000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $72000.0 in Q2 2023 to a low of -$524000.0 in Q4 2023.
  • A 4-year average of -$68428.6 and a median of -$15000.0 in 2022 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 253.19% in 2023; the steepest drop was 2657.89% in 2023.
  • Precision Biosciences' Other Operating Expenses stood at -$19000.0 in 2022, then plummeted by 2657.89% to -$524000.0 in 2023, then skyrocketed by 65.27% to -$182000.0 in 2024, then surged by 101.65% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other Operating Expenses are $3000.0 (Q3 2025), -$25000.0 (Q2 2025), and -$9000.0 (Q1 2025).